(Total Views: 748)
Posted On: 01/04/2023 10:14:29 PM
Post# of 154113
An update was posted today on clinicaltrials.gov for:
Study to Evaluate the Efficacy and Safety of Leronlimab for Mild to Moderate COVID-19
Per a quick look, they appear to have responded to some QC review comments by the National Library of Medicine and added some NEWS2 score info. Not sure it is important since they are not going after Covid, but at least it shows they are still "taking care of business" in addition to working on the big 3 (NASH, HIV and oncology).
If any one sees some new relevant info here, please post.
https://clinicaltrials.gov/ct2/show/results/N...;lupd_d=14
Study to Evaluate the Efficacy and Safety of Leronlimab for Mild to Moderate COVID-19
Per a quick look, they appear to have responded to some QC review comments by the National Library of Medicine and added some NEWS2 score info. Not sure it is important since they are not going after Covid, but at least it shows they are still "taking care of business" in addition to working on the big 3 (NASH, HIV and oncology).
If any one sees some new relevant info here, please post.
https://clinicaltrials.gov/ct2/show/results/N...;lupd_d=14
(7)
(0)
